奥利万星
基于1个网页-相关网页
Oritavancin has gone through several drugmakers, including InterMune, and was rejected basically because too much of its pivotal data is years old, from before resistant bugs were much of a problem.
FORBES: The Antibiotics I Missed
应用推荐
模块上移
模块下移
不移动